Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1961 1
1962 3
1965 1
1969 1
1971 1
1972 1
1973 3
1974 4
1975 1
1976 2
1977 5
1978 6
1979 2
1980 3
1981 3
1982 3
1983 4
1984 1
1985 7
1986 6
1987 9
1988 10
1989 10
1990 6
1991 8
1992 7
1993 12
1994 9
1995 11
1996 24
1997 29
1998 20
1999 26
2000 17
2001 19
2002 28
2003 42
2004 53
2005 55
2006 54
2007 91
2008 88
2009 87
2010 144
2011 145
2012 194
2013 248
2014 256
2015 319
2016 342
2017 364
2018 418
2019 509
2020 624
2021 702
2022 878
2023 874
2024 473

Text availability

Article attribute

Article type

Publication date

Search Results

6,527 results

Results by year

Filters applied: . Clear all
Page 1
Repotrectinib in ROS1 Fusion-Positive Non-Small-Cell Lung Cancer.
Drilon A, Camidge DR, Lin JJ, Kim SW, Solomon BJ, Dziadziuszko R, Besse B, Goto K, de Langen AJ, Wolf J, Lee KH, Popat S, Springfeld C, Nagasaka M, Felip E, Yang N, Velcheti V, Lu S, Kao S, Dooms C, Krebs MG, Yao W, Beg MS, Hu X, Moro-Sibilot D, Cheema P, Stopatschinskaja S, Mehta M, Trone D, Graber A, Sims G, Yuan Y, Cho BC; TRIDENT-1 Investigators. Drilon A, et al. Among authors: yang n. N Engl J Med. 2024 Jan 11;390(2):118-131. doi: 10.1056/NEJMoa2302299. N Engl J Med. 2024. PMID: 38197815 Clinical Trial.
Apoptosis releases hydrogen sulfide to inhibit Th17 cell differentiation.
Ou Q, Qiao X, Li Z, Niu L, Lei F, Cheng R, Xie T, Yang N, Liu Y, Fu L, Yang J, Mao X, Kou X, Chen C, Shi S. Ou Q, et al. Among authors: yang n. Cell Metab. 2024 Jan 2;36(1):78-89.e5. doi: 10.1016/j.cmet.2023.11.012. Epub 2023 Dec 18. Cell Metab. 2024. PMID: 38113886 Free article.
Perioperative Toripalimab Plus Chemotherapy for Patients With Resectable Non-Small Cell Lung Cancer: The Neotorch Randomized Clinical Trial.
Lu S, Zhang W, Wu L, Wang W, Zhang P; Neotorch Investigators; Fang W, Xing W, Chen Q, Yang L, Mei J, Tan L, Sun X, Xu S, Hu X, Yu G, Yu D, Yang N, Chen Y, Shan J, Xing L, Tian H, Zhang X, Zhou M, Fang H, Wu G, Liu Y, Ye M, Cao L, Jiang J, Li X, Zhu L, Li D, Kang M, Zhong A, Chen K, Wu N, Sun Q, Ma H, Cai K, Wang C, Lin G, Zhu K, Zhang Y, Zhang X, Hu H, Zhang W, Chen J, Yang Z, Hang X, Hu J, Huang Y, Zhang Z, Zhang L, Zhang L, Liu L, Lin D, Zhang J, Chen G, Li Y, Zhu L, Wang W, Yu W, Cao D, Keegan P, Yao S. Lu S, et al. Among authors: yang n. JAMA. 2024 Jan 16;331(3):201-211. doi: 10.1001/jama.2023.24735. JAMA. 2024. PMID: 38227033 Clinical Trial.
Surfaceome analysis of extracellular vesicles from senescent cells uncovers uptake repressor DPP4.
Meng Q, Chen C, Yang N, Gololobova O, Shi C, Dunn CA, Rossi M, Martindale JL, Basisty N, Ding J, Delannoy M, Basu S, Mazan-Mamczarz K, Shin CH, Yang JH, Johnson PF, Witwer KW, Biragyn A, Sen P, Abdelmohsen K, De S, Gorospe M. Meng Q, et al. Among authors: yang n. Proc Natl Acad Sci U S A. 2023 Oct 24;120(43):e2219801120. doi: 10.1073/pnas.2219801120. Epub 2023 Oct 20. Proc Natl Acad Sci U S A. 2023. PMID: 37862381 Free PMC article.
Review on pharmacological effects of gastrodin.
Xiao G, Tang R, Yang N, Chen Y. Xiao G, et al. Among authors: yang n. Arch Pharm Res. 2023 Oct;46(9-10):744-770. doi: 10.1007/s12272-023-01463-0. Epub 2023 Sep 25. Arch Pharm Res. 2023. PMID: 37749449 Review.
A toxicological review of alkaloids.
Yang N, Guo J, Zhang J, Gao S, Xiang Q, Wen J, Huang Y, Rao C, Chen Y. Yang N, et al. Drug Chem Toxicol. 2024 Mar 11:1-15. doi: 10.1080/01480545.2024.2326051. Online ahead of print. Drug Chem Toxicol. 2024. PMID: 38465444 Review.
Metabolic dysregulation of lymphocytes in autoimmune diseases.
Wang S, Yang N, Zhang H. Wang S, et al. Among authors: yang n. Trends Endocrinol Metab. 2024 Feb 13:S1043-2760(24)00019-5. doi: 10.1016/j.tem.2024.01.005. Online ahead of print. Trends Endocrinol Metab. 2024. PMID: 38355391 Review.
Therapeutic potential of targeting polo-like kinase 4.
Lei Q, Yu Q, Yang N, Xiao Z, Song C, Zhang R, Yang S, Liu Z, Deng H. Lei Q, et al. Among authors: yang n. Eur J Med Chem. 2024 Feb 5;265:116115. doi: 10.1016/j.ejmech.2023.116115. Epub 2024 Jan 3. Eur J Med Chem. 2024. PMID: 38199166 Review.
6,527 results